These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 19585507

  • 1. The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: an observational retrospective analysis of invasive cervical cancers.
    Powell N, Boyde A, Tristram A, Hibbitts S, Fiander A.
    Int J Cancer; 2009 Nov 15; 125(10):2425-7. PubMed ID: 19585507
    [Abstract] [Full Text] [Related]

  • 2. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX, Retrospective International Survey and HPV Time Trends Study Group.
    Lancet Oncol; 2010 Nov 15; 11(11):1048-56. PubMed ID: 20952254
    [Abstract] [Full Text] [Related]

  • 3. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.
    Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE.
    J Natl Cancer Inst; 2009 Apr 01; 101(7):475-87. PubMed ID: 19318628
    [Abstract] [Full Text] [Related]

  • 4. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
    Brotherton JML, Tabrizi SN, Phillips S, Pyman J, Cornall AM, Lambie N, Anderson L, Cummings M, Payton D, Scurry JP, Newman M, Sharma R, Saville M, Garland SM.
    Int J Cancer; 2017 Oct 15; 141(8):1576-1584. PubMed ID: 28677147
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X, Díaz M, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group.
    J Natl Cancer Inst; 2006 Mar 01; 98(5):303-15. PubMed ID: 16507827
    [Abstract] [Full Text] [Related]

  • 7. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
    Bao YP, Li N, Smith JS, Qiao YL.
    Int J STD AIDS; 2008 Feb 01; 19(2):106-11. PubMed ID: 18334063
    [Abstract] [Full Text] [Related]

  • 8. Distribution of human papillomavirus genotypes in archival cervical tissue from women with cervical cancer in urban Sri Lanka.
    Samarawickrema NA, Tabrizi SN, Hewavisenthi J, Leong T, Garland SM.
    Int J Gynaecol Obstet; 2011 Nov 01; 115(2):180-2. PubMed ID: 21872246
    [Abstract] [Full Text] [Related]

  • 9. HPV genotyping from invasive cervical cancer in Chile.
    Roa JC, Garcia P, Gomez J, Fernández W, Gaete F, Espinoza A, Lepetic A, Suarez E.
    Int J Gynaecol Obstet; 2009 May 01; 105(2):150-3. PubMed ID: 19249046
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of high-risk human papillomavirus type 16 and 18 in oral and cervical cancers in population from Gujarat, West India.
    Patel KR, Vajaria BN, Begum R, Desai A, Patel JB, Shah FD, Shukla SN, Patel PS.
    J Oral Pathol Med; 2014 Apr 01; 43(4):293-7. PubMed ID: 24372728
    [Abstract] [Full Text] [Related]

  • 11. Human Papillomavirus-Related Cancers.
    Li Y, Xu C.
    Adv Exp Med Biol; 2017 Apr 01; 1018():23-34. PubMed ID: 29052130
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus type distribution in cervical cancer in Delhi, India.
    Bhatla N, Dar L, Patro AR, Kriplani A, Gulati A, Verma K, Broor S, Shah KV, Gravitt PE.
    Int J Gynecol Pathol; 2006 Oct 01; 25(4):398-402. PubMed ID: 16990719
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Berman TA, Schiller JT.
    Cancer; 2017 Jun 15; 123(12):2219-2229. PubMed ID: 28346680
    [Abstract] [Full Text] [Related]

  • 14. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
    van Aardt MC, Dreyer G, Pienaar HF, Karlsen F, Hovland S, Richter KL, Becker P.
    Int J Gynecol Cancer; 2015 Jun 15; 25(5):919-25. PubMed ID: 25950128
    [Abstract] [Full Text] [Related]

  • 15. Modern screening in cervical cancer. Perspectives of HPV prophylactic vaccines.
    Vlădăreanu R, Andrei C.
    Rev Med Chir Soc Med Nat Iasi; 2007 Jun 15; 111(1):144-54. PubMed ID: 17595860
    [Abstract] [Full Text] [Related]

  • 16. Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK).
    Powell N, Cuschieri K, Cubie H, Hibbitts S, Rosillon D, De Souza SC, Molijn A, Quint W, Holl K, Fiander A.
    J Clin Virol; 2013 Nov 15; 58(3):571-4. PubMed ID: 24051043
    [Abstract] [Full Text] [Related]

  • 17. Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.
    Alemany L, de Sanjosé S, Tous S, Quint W, Vallejos C, Shin HR, Bravo LE, Alonso P, Lima MA, Guimerà N, Klaustermeier J, Llombart-Bosch A, Kasamatsu E, Tatti SA, Felix A, Molina C, Velasco J, Lloveras B, Clavero O, Lerma E, Laco J, Bravo IG, Guarch R, Pelayo A, Ordi J, Andújar M, Sanchez GI, Castellsagué X, Muñoz N, Bosch FX, RIS HPV TT Study Group.
    Int J Cancer; 2014 Jul 01; 135(1):88-95. PubMed ID: 24382655
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D.
    Gynecol Oncol; 2008 Sep 01; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.